FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1503294809> ?p ?o ?g. }

• W1503294809 endingPage "542" @default.
• W1503294809 startingPage "537" @default.
• W1503294809 abstract "Purpose: To evaluate the long-term outcome of phenobarbital treatment for convulsive epilepsy in rural China, and to explore factors associated with overall seizure outcomes. Methods: We carried out follow-up assessments of people who took part in an epilepsy community management program conducted in rural counties of six provinces in China. People with convulsive epilepsy who were previously untreated (or on irregular treatment) were commenced on regular treatment with phenobarbital. Information was collected using a standardized questionnaire by face-to-face interviews of the individuals (and their families where necessary). Information collected included treatment status, medication change, seizure frequency, and mortality. Key Findings: Among the 2,455 people who participated in the original program, outcomes were successfully ascertained during the follow-up assessment in 1986. Among them, 206 had died. Information on treatment response was obtained in 1,780 (56% male; mean age 33.9 years, range 3–84; mean duration of follow-up 6.4 years). Among them, 939 (53%) were still taking phenobarbital. The most common reasons for stopping phenobarbital were seizure freedom or substantial seizure reduction, socioeconomic reasons, and personal preference. Four hundred fifty-three individuals (25%) became seizure-free for at least 1 year while taking phenobarbital, 88% of whom did so at daily doses of 120 mg or below. Four hundred six (23%) reported adverse events, which led to withdrawal of phenobarbital in <1%. The most common adverse effects were malaise/somnolence (7.4%), dizziness (3%), and lethargy (2.6%). At the follow-up assessment, 688 (39%) individuals had been seizure free for at least the previous year. People with persistent seizures had significantly longer duration of epilepsy and higher number of seizures in the 12 months before treatment. People who were taking AED treatment irregularly at recruitment were less likely to become seizure-free. Significance: We observed long-term benefits of regular treatment with phenobarbital for convulsive epilepsy in rural China. One hundred years after the discovery of its antiepileptic effect, phenobarbital is still playing an important role in the management of epilepsy." @default.
• W1503294809 created "2016-06-24" @default.
• W1503294809 creator A5000174970 @default.
• W1503294809 creator A5010101372 @default.
• W1503294809 creator A5012894495 @default.
• W1503294809 creator A5021639465 @default.
• W1503294809 creator A5035657409 @default.
• W1503294809 creator A5040773949 @default.
• W1503294809 creator A5044713086 @default.
• W1503294809 creator A5055974601 @default.
• W1503294809 creator A5056967488 @default.
• W1503294809 creator A5065990541 @default.
• W1503294809 creator A5067443324 @default.
• W1503294809 creator A5074342471 @default.
• W1503294809 creator A5075058158 @default.
• W1503294809 creator A5089246765 @default.
• W1503294809 date "2012-11-13" @default.
• W1503294809 modified "2023-09-30" @default.
• W1503294809 title "Long-term outcome of phenobarbital treatment for epilepsy in rural China: A prospective cohort study" @default.
• W1503294809 cites W1521361249 @default.
• W1503294809 cites W1523466287 @default.
• W1503294809 cites W1759829149 @default.
• W1503294809 cites W1991097570 @default.
• W1503294809 cites W1994572997 @default.
• W1503294809 cites W1999195742 @default.
• W1503294809 cites W2002776910 @default.
• W1503294809 cites W2023881475 @default.
• W1503294809 cites W2028500192 @default.
• W1503294809 cites W2058147010 @default.
• W1503294809 cites W2073509001 @default.
• W1503294809 cites W2089297815 @default.
• W1503294809 cites W2090276138 @default.
• W1503294809 cites W2093228194 @default.
• W1503294809 cites W2116686895 @default.
• W1503294809 cites W2136088196 @default.
• W1503294809 cites W2142513697 @default.
• W1503294809 doi "https://doi.org/10.1111/epi.12022" @default.
• W1503294809 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23163288" @default.
• W1503294809 hasPublicationYear "2012" @default.
• W1503294809 type Work @default.
• W1503294809 sameAs 1503294809 @default.
• W1503294809 citedByCount "24" @default.
• W1503294809 countsByYear W15032948092012 @default.
• W1503294809 countsByYear W15032948092013 @default.
• W1503294809 countsByYear W15032948092014 @default.
• W1503294809 countsByYear W15032948092015 @default.
• W1503294809 countsByYear W15032948092017 @default.
• W1503294809 countsByYear W15032948092018 @default.
• W1503294809 countsByYear W15032948092019 @default.
• W1503294809 countsByYear W15032948092020 @default.
• W1503294809 countsByYear W15032948092021 @default.
• W1503294809 countsByYear W15032948092022 @default.
• W1503294809 countsByYear W15032948092023 @default.
• W1503294809 crossrefType "journal-article" @default.
• W1503294809 hasAuthorship W1503294809A5000174970 @default.
• W1503294809 hasAuthorship W1503294809A5010101372 @default.
• W1503294809 hasAuthorship W1503294809A5012894495 @default.
• W1503294809 hasAuthorship W1503294809A5021639465 @default.
• W1503294809 hasAuthorship W1503294809A5035657409 @default.
• W1503294809 hasAuthorship W1503294809A5040773949 @default.
• W1503294809 hasAuthorship W1503294809A5044713086 @default.
• W1503294809 hasAuthorship W1503294809A5055974601 @default.
• W1503294809 hasAuthorship W1503294809A5056967488 @default.
• W1503294809 hasAuthorship W1503294809A5065990541 @default.
• W1503294809 hasAuthorship W1503294809A5067443324 @default.
• W1503294809 hasAuthorship W1503294809A5074342471 @default.
• W1503294809 hasAuthorship W1503294809A5075058158 @default.
• W1503294809 hasAuthorship W1503294809A5089246765 @default.
• W1503294809 hasBestOaLocation W15032948091 @default.
• W1503294809 hasConcept C118552586 @default.
• W1503294809 hasConcept C126322002 @default.
• W1503294809 hasConcept C15744967 @default.
• W1503294809 hasConcept C187212893 @default.
• W1503294809 hasConcept C197934379 @default.
• W1503294809 hasConcept C2777260799 @default.
• W1503294809 hasConcept C2778186239 @default.
• W1503294809 hasConcept C2778793413 @default.
• W1503294809 hasConcept C2779034229 @default.
• W1503294809 hasConcept C71924100 @default.
• W1503294809 hasConcept C72563966 @default.
• W1503294809 hasConceptScore W1503294809C118552586 @default.
• W1503294809 hasConceptScore W1503294809C126322002 @default.
• W1503294809 hasConceptScore W1503294809C15744967 @default.
• W1503294809 hasConceptScore W1503294809C187212893 @default.
• W1503294809 hasConceptScore W1503294809C197934379 @default.
• W1503294809 hasConceptScore W1503294809C2777260799 @default.
• W1503294809 hasConceptScore W1503294809C2778186239 @default.
• W1503294809 hasConceptScore W1503294809C2778793413 @default.
• W1503294809 hasConceptScore W1503294809C2779034229 @default.
• W1503294809 hasConceptScore W1503294809C71924100 @default.
• W1503294809 hasConceptScore W1503294809C72563966 @default.
• W1503294809 hasIssue "3" @default.
• W1503294809 hasLocation W15032948091 @default.
• W1503294809 hasLocation W15032948092 @default.
• W1503294809 hasOpenAccess W1503294809 @default.
• W1503294809 hasPrimaryLocation W15032948091 @default.
• W1503294809 hasRelatedWork W1503294809 @default.
• W1503294809 hasRelatedWork W1963608697 @default.

• next